Annemarie Hanekamp
CIK: 0002118987
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BNTX
BioNTech SE
Officer
Discretionary Trading P&L
Holdings
About Hanekamp Annemarie
Hanekamp Annemarie (SEC CIK 0002118987) files insider reports with the SEC as Chief Commercial Officer of BioNTech SE (BNTX).
Signal8 holds 2 ownership filings by Hanekamp Annemarie (1 Form 3, 1 Form 4), filed between Mar 18, 2026 and May 13, 2026. Those filings report 2 transactions, the latest on May 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hanekamp Annemarie's filings is in MAINZ.
Recent filings by Hanekamp Annemarie
- May 12, 2026: Grants or awards of BNTX derivative securities (2 lines, Form 4, code A).
Other insiders filing for BioNTech SE (BNTX)
- Sahin Ugur, Chief Executive Officer
- Low-Friedrich Iris Katharina, Director
- Schaffert Susanne, Director
- Zapata Gomez Ramon, Chief Financial Officer
- Ryan James Timothy Patrick
- Poetting Sierk, Chief Operating Officer